Benralizumab as a glucocorticoid-sparing treatment option for severe asthma in eosinophilic granulomatosis with polyangiitis

J Allergy Clin Immunol Pract. 2020 Oct;8(9):3225-3227.e2. doi: 10.1016/j.jaip.2020.05.033. Epub 2020 Jun 4.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Asthma* / drug therapy
  • Churg-Strauss Syndrome* / diagnosis
  • Churg-Strauss Syndrome* / drug therapy
  • Eosinophils
  • Glucocorticoids / therapeutic use
  • Granulomatosis with Polyangiitis*
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • benralizumab